SARS-CoV-2 antibodies in Colombian urban area: follow-up on occupational groups
DOI:
https://doi.org/10.15649/cuidarte.4029Keywords:
COVID-19, COVID-19 Serological Testing, Occupational HealthAbstract
Highlights
- This study reveals diverse levels of SARS-CoV-2 exposure among occupational groups in Bucaramanga, highlighting the vulnerability of informal workers.
- Adjusted seroprevalence progressively increased during the pandemic, reaching 29.2% in the third round among workers in the Bucaramanga Metropolitan Area.
- Healthcare workers accounted for over 50% of the participants, emphasizing their significant involvement in the study.
- Hybrid immunity emerges as a factor more associated with infection than vaccination, underscoring the importance of targeted interventions to protect vulnerable groups.
Introduction: Globally, the COVID-19 pandemic typically relied on reported cases, but a more comprehensive view emerges from antibody identification. A 2020 national study in Bucaramanga revealed diverse SARS-CoV-2 exposure levels among occupational groups, emphasizing the vulnerability of informal workers. Objective: This study estimates adjusted seroprevalence and seroincidence of SARS-CoV-2 antibodies (IgM and IgG) among occupational groups in the Bucaramanga Metropolitan Area (Colombia) in three different moments of the pandemic. Materials and Methods: The prospective cohort study was conducted from September 2020 to October 2021, comprising three rounds. Each round gathered demographic data, medical history, COVID exposure or diagnosis, and vaccination status from workers across various occupational groups in Bucaramanga and its metropolitan area. Immunoglobulins G and M were assessed in each round, and adjusted seroprevalence was calculated. Results: A total of 1,013 subjects participated in all rounds. Healthcare workers accounted for more than 50% of all participants. By Round 3, 93.6% (n = 948) of participants had received the vaccination. Adjusted seroprevalence increased progressively (Round 1: 15.9% [95%CI 13.7–18.2]; Round 2: 18.4% [95%CI 16.0–20.7]; Round 3: 29.2% [95%CI 26.4–31.9]). Seroincidence for IgM/IgG positivity by Round 3 was 26.2% (95%CI 20.7–31.6). Discussion: The progressive increase in adjusted SARS-CoV-2 seroprevalence among workers in the Metropolitan Area of Bucaramanga is highlighted, with a notable prevalence among healthcare workers. Conclusions: The study underscores the prevalence of SARS-CoV-2 infection among workers in the Bucaramanga Metropolitan Area, emphasizing the role of hybrid immunity following vaccination in infection rates. Continued monitoring and tailored interventions are vital for protecting vulnerable populations.
How to cite this article: Colmenares-Mejía Claudia C, Quintero-Lesmes Doris C, Serrano Norma C, Meneses Ligia, Salazar Acosta Isail, Idrovo Álvaro J, Sanabria-Echeverry Duván Y, Cordero Rebolledo Helmer, Castillo Víctor. SARS-CoV-2 antibodies in Colombian urban area: follow-up on occupational groups. Revista Cuidarte. 2025;16(2):e4029. https://doi.org/10.15649/cuidarte.4029
References
Cavataio J, Schnell S. Interpreting SARS-CoV-2 seroprevalence, deaths, and fatality rate — Making a case for standardized reporting to improve communication. Math Biosci 2021;333:108545. https://doi.org/https://doi.org/10.1016/j.mbs.2021.108545
Arora RK, Joseph A, Van Wyk J, Rocco S, Atmaja A, May E, et al. SeroTracker: a global SARS-CoV-2 seroprevalence dashboard. Lancet Infect Dis 2021;21:e75–6. https://doi.org/10.1016/S1473-3099(20)30631-9
Shultz JM, Berg RC, Bernal Acevedo OA, Ocampo Cañas JA, Escobar VAP, Muñoz O, et al. Complex correlates of Colombia’s COVID-19 surge. Lancet Regional Health - Americas 2021;3. https://doi.org/10.1016/J.LANA.2021.100072
Idrovo AJ. Long but Unreal Lockdowns in Latin America. Comment on Chen, Y.T.; Yen, Y.F.; Yu, S.H.; Su, E.C. An Examination on the Transmission of COVID-19 and the Effect of Response Strategies: A Comparative Analysis. Int. J. Environ. Res. Public Health 2020, 17, E5687. Int J Environ Res Public Health 2020;17:1–2. https://doi.org/10.3390/IJERPH17218064
Moreno-Montoya J, Rodríguez-Villamizar LA, Idrovo AJ. Massive social protests amid the pandemic in selected Colombian cities: Did they increase COVID-19 cases? medRxiv 2021:2021.06.16.21258989. https://doi.org/10.1101/2021.06.16.21258989
Idrovo AJ. More social discontent than pandemic-related risk perception in Colombia. The Lancet 2021;398(10296):211. https://doi.org/10.1016/S0140-6736(21)01239-3
Mercado-Reyes M, Malagón-Rojas J, Rodríguez-Barraquer I, Zapata-Bedoya S, Wiesner M, Cucunubá Z, et al. Seroprevalence of anti-SARS-CoV-2 antibodies in Colombia, 2020: A population-based study. The Lancet Regional Health - Americas 2022;9. https://doi.org/10.1016/j.lana.2022.100195
Departamento Administrativo Nacional de Estadística -DANE. Censo Nacional de Población y Vivienda - CNPV – 2018. Colombia. Consulta: Junio 19, 2024. Disponible en: https://microdatos.dane.gov.co/index.php/catalog/643
Colmenares-Mejía CC, Serrano-Díaz N, Quintero-Lesmes DC, Meneses L, Salazar Acosta I, Idrovo ÁJ, et al. Seroprevalence of SARS-CoV-2 Infection among Occupational Groups from the Bucaramanga Metropolitan Area, Colombia. Int J Environ Res Public Health 2021;18(8):4172. https://doi.org/10.3390/IJERPH18084172
Arregocés-Castillo L, Fernández-Niño J, Rojas-Botero M, Palacios-Clavijo A, Galvis-Pedraza M, Rincón-Medrano L, et al. Effectiveness of COVID-19 vaccines in older adults in Colombia: a retrospective, population-based study of the ESPERANZA cohort. Lancet Healthy Longev 2022;3(4):e242–52. https://doi.org/10.1016/S2666-7568(22)00035-6
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: Building an international community of software platform partners., Journal of Biomedical Informatics. Academic Press Inc., 2019;95. https://doi.org/10.1016/j.jbi.2019.103208
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–81. https://doi.org/10.1016/J.JBI.2008.08.010
Esri. Cobertura de datos de geocodificación—Ayuda de ArcGIS Online | Documentación Consulta: Junio 19, 2024. Disponible en: https://doc.arcgis.com/es/arcgis-online/reference/geocode-coverage.htm
Mercado Reyes M, Zabaleta G, Rubio VV, Casallas Cifuentes H, Herrera Hernández A. Validación secundaria y verificación del desempeño de la prueba serológica “SARS-CoV-2 IgG para uso en Architect – Abbott.” 2020. Consulta: Junio 19, 2024. Disponible en: https://www.ins.gov.co/BibliotecaDigital/validacion-prueba-serologica-sars-CoV-2-Igg-architect-Abbott.pdf
Colmenares-Mejía CC, Quintero-Lesmes DC, Serrano NC, Meneses L, Salazar Acosta I, Idrovo AJ, Sanabria-Echeverry DY, Cordero Rebolledo H, Castillo V. Antibodies · GitLab. 2024. https://gitlab.com/investigaciones1/antibodies
Sempos CT, Tian L. Adjusting Coronavirus Prevalence Estimates for Laboratory Test Kit Error. Am J Epidemiol 2021;190:109–15. https://doi.org/10.1093/aje/kwaa174
Idrovo AJ, Manrique EF, Nieves Cuervo GM. Crónica de una pandemia anunciada: caso Santander (Parte 1). Salud UIS 2020;52(3). https://doi.org/10.18273/REVSAL.V52N3-2020005
Rodriguez-Villamizar LA, Torres-Prieto A, Martínez-Vega RA, Vera-Cala LM. Epidemia por COVID-19 en Santander 2020: análisis epidemiológico desde un enfoque territorial por provincias. Salud UIS 2021;53. https://doi.org/10.18273/SALUDUIS.53.E:21040
Cifuentes MP, Rodriguez-Villamizar LA, Rojas-Botero ML, Alvarez-Moreno CA, Fernández-Niño JA. Socioeconomic inequalities associated with mortality for COVID-19 in Colombia: a cohort nationwide study. J Epidemiol Community Health 2021;75:610–5. https://doi.org/10.1136/JECH-2020-216275
Herrington DM, Sanders JW, Wierzba TF, Alexander-Miller M, Espeland M, Bertoni AG, et al. Duration of SARS-CoV-2 sero-positivity in a large longitudinal sero-surveillance cohort: the COVID-19 Community Research Partnership. BMC Infect Dis 2021;21. https://doi.org/10.1186/S12879-021-06517-6
Shioda K, Lopman B. How to interpret the total number of SARS-CoV-2 infections. Lancet 2022;399(10344):2326-2327. https://doi.org/10.1016/S0140-6736(22)00629-8
License
Copyright (c) 2025 Revista Cuidarte
This work is licensed under a Creative Commons Attribution 4.0 International License.
Journal Cuidarte, scientific publication of open access, is licensed under a Creative Commons Attribution (CC BY-NC), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Any other form of use such as reproduction, transformation, public communication or distribution, for profit, requires the prior authorization of the University of Santander UDES.
The names and e-mail addresses entered in the Journal Cuidarte will be used exclusively for the purposes stated by this magazine and will not be available for any other purpose or other person.
The articles published in the Journal Cuidarte represent the criteria of their authors and do not necessarily constitute the official opinion of the University of Santander UDES.
